BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20410173)

  • 1. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.
    Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells.
    Garofalo C; Sisci D; Surmacz E
    Clin Cancer Res; 2004 Oct; 10(19):6466-75. PubMed ID: 15475434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation.
    Binai NA; Carra G; Löwer J; Löwer R; Wessler S
    Endocrine; 2013 Oct; 44(2):496-503. PubMed ID: 23412922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
    Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
    BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
    Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
    Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
    Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
    Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.
    Huang B; Omoto Y; Iwase H; Yamashita H; Toyama T; Coombes RC; Filipovic A; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1933-8. PubMed ID: 24449868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
    Zhang X; Mukerji R; Samadi AK; Cohen MS
    BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice.
    Hubert A; Bochenek ML; Schütz E; Gogiraju R; Münzel T; Schäfer K
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1683-1697. PubMed ID: 28705795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures.
    Cartaxo AL; Estrada MF; Domenici G; Roque R; Silva F; Gualda EJ; Loza-Alvarez P; Sflomos G; Brisken C; Alves PM; André S; Brito C
    J Exp Clin Cancer Res; 2020 Aug; 39(1):161. PubMed ID: 32807212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.
    Sisci D; Maris P; Cesario MG; Anselmo W; Coroniti R; Trombino GE; Romeo F; Ferraro A; Lanzino M; Aquila S; Maggiolini M; Mauro L; Morelli C; Andò S
    Cell Cycle; 2013 Nov; 12(21):3405-20. PubMed ID: 24047697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
    Swetzig WM; Wang J; Das GM
    Oncotarget; 2016 Mar; 7(13):16049-69. PubMed ID: 26909605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.
    Hu X; Juneja SC; Maihle NJ; Cleary MP
    J Natl Cancer Inst; 2002 Nov; 94(22):1704-11. PubMed ID: 12441326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.